Abstract
At our center 62 renal transplantations (31 living donor and 31 cadaveric donor grafts) have been performed in 58 patients with amyloid renal disease since 1974. The amyloidosis was secondary to rheumatic disease in 74% of the patients. Predialytic transplantation was performed in 28% of the patients. Mean follow-up time was 5.1 years (0.3–14.5 years). One-year actuarial patient survival was 79%, decreasing to 65% after 5 years. First graft survival was 74% at 1 year and 62% at 5 years. Patient death with a functioning graft caused 16 out of 25 graft losses. Infections caused 11 out of 18 deaths (61%), more than half of them within 3 months. Renal transplant amyloid was diagnosed in about 10% of the cases (6/62); however, only about 3% of the grafts (2/62) were lost. These long-term results encourage transplantation in amyloid renal end-stage disease.
Similar content being viewed by others
References
Advisory Committee to the Renal Transplant Registry (1975) Renal transplantation in congenital and metabolic disorders. A report from the ASC/NIH Renal Transplant Registry. JAMA 252:148–153
Ahlmen M, Ahlmen J, Svalander C, Bucht H (1987) Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency. Clin Rheumatol 6: 27–38
Belzer F, Ashby B, Gulyassy P, Powell M (1968) Successful seventeen-hour preservation and transplantation of human-cadaver kidney. N Engl J Med 278:608–610
Benson MD, Skinner M, Cohen AS (1977) Amyloid deposition in a renal transplant in familial Mediterranean fever. Ann Int Med 87:31–34
Browning M, Banks R, Tribe C, Bacon P, Hollingsworth P, Kingswood C, Poulding J, Harrison P, Mackenzie C (1983) Renal involvement in systemic amyloidosis. Proc EDTA 20: 595–600
Cohen AS (1967) Amyloidosis. N Engl J Med 277:628–638
Glenner GG (1980) Amyloid deposits and amyloidosis. The beta-fibrilloses II. N Engl J Med 302:1333–1343
Hawkins PN, Lavender JP, Pepys MB (1990) Evaluation of systemic amyloidosis by scintigraphy with 123I-labelled serum amyloid P component. N Engl J Med 323:508–513
Heering P, Kutkuhn B, Frenzel H, Linke RP, Grabensee B (1979) Renal transplantation in amyloid nephropathy. Int Urol Nephrol 21:339–347
Isoniemi H, Eklund B, Höckerstedt K, Salmela K, Ahonen J (1989) Renal transplantation in amyloidosis. Transplant Proc 21:2039–2040
Jones NF (1976) Renal amyloidosis. Pathogenesis and therapy. Clin Nephrol 6:459–464
Kennedy CL, Castro JE (1977) Transplantation for renal amyloidosis. Transplantation 24:382–385
Kuhlbäck B, Falck H, Törnroth T, Wallenius M, Lindström BL, Pasternack A (1979) Renal transplantation in amyloidosis. Acta Med Scand 205:169–172
Kyle RA, Wagoner RD, Holley KE (1982) Primary systemic amyloidosis. Resolution of the nephrotic syndrome with melphalan and prednisone. Arch Intern Med 142:1445–1447
Leading article (1980) Treatment of renal amyloidosis. Lancet I: 1062–1063
Najarian JS, Frey DJ, Matas AJ, Gillingham KJ, So SSK, Cook M, Chavers B, Mauer SM, Nevins TE (1990) Renal transplantations in infants. Ann Surg 212:353–365
Pasternack A, Ahonen J, Kulbäck B (1986) Renal transplantation in 45 patients with amyloidosis. Transplantation 6:598–601
Pepys MB (1988) Amyloidosis: some recent developments. Q J Med 67:283–298
Pras M, Gafni J, Jacob ET, Cabili S, Zemer D, Sohar E (1984) Recent advances in familial Mediterranean fever. Adv Nephrol 13:261–270
Styrt B (1990) Infection associated with asplenia: risks, mechanisms and prevention. Am J Med 88:33N-42N
Törnroth T, Falck HM, Wegelius O (1985) Renal pathology in amyloidosis. Scand J Urol Nephrol [Suppl] 90:9–21
Author information
Authors and Affiliations
About this article
Cite this article
Hartmann, A., Holdaas, H., Fauchald, P. et al. Fifteen years' experience with renal transplantation in systemic amyloidosis. Transplant Int 5, 15–18 (1992). https://doi.org/10.1007/BF00337183
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00337183